These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10171744)

  • 1. An analysis of substance abuse patterns, medical expenses and effectiveness of treatment in the workplace: long-term followup.
    Worner TM; Chen PJ; Ma H; Xu S; McCarthy EG
    Empl Benefits J; 1993 Dec; 18(4):15-9. PubMed ID: 10171744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of substance abuse patterns, medical expenses and effectiveness of treatment in the workplace.
    Yu J; Chen PJ; Harshman EJ; McCarthy EG
    Empl Benefits J; 1991 Sep; 16(3):26-30. PubMed ID: 10170845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focused psychiatric review: impacts on expense and utilization.
    Gotowka TD; Smith RB
    Benefits Q; 1991; 7(4):73-81. PubMed ID: 10170927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and benefit-cost of peer-based workplace substance abuse prevention coupled with random testing.
    Miller TR; Zaloshnja E; Spicer RS
    Accid Anal Prev; 2007 May; 39(3):565-73. PubMed ID: 17125723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance abuse and the uninsured worker in the United States.
    Galvin DM; Miller TR; Spicer RS; Waehrer GM
    J Public Health Policy; 2007; 28(1):102-17. PubMed ID: 17363941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wellness programs slow rising costs.
    Cooper EJ
    J Healthc Prot Manage; 1992-1993 Winter; 9(1):95-102. PubMed ID: 10124928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year trajectories of health care utilization and cost in a drug and alcohol treatment sample.
    Parthasarathy S; Weisner CM
    Drug Alcohol Depend; 2005 Nov; 80(2):231-40. PubMed ID: 15916868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the EAP in the identification and treatment of substance abuse.
    Kramer RM
    Clin Lab Med; 1998 Dec; 18(4):747-53, x. PubMed ID: 9891612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onsite concurrent review: impacts on utilization, medical complications and expense.
    Smith RB; Gotowka TD
    Benefits Q; 1991; 7(4):82-90. PubMed ID: 10116961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health promotion in the workplace: alcohol and drug abuse. Report of a WHO Expert Committee.
    World Health Organ Tech Rep Ser; 1993; 833():1-34. PubMed ID: 8367980
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness of alcohol and drug treatment programs.
    Caldwel JR
    J Fla Med Assoc; 1993 Jun; 80(6):385-6. PubMed ID: 8340771
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug treatment takes a hit. As substance abuse has surged among teens, coverage for care has been curtailed.
    Gardner J
    Mod Healthc; 1996 Oct; 26(43):66, 68, 70-2. PubMed ID: 10172795
    [No Abstract]   [Full Text] [Related]  

  • 16. Survey search: prevalence/effects of newer mental health care and cost management programs.
    Health Cost Manage; 1987; 4(2):28-35. PubMed ID: 10317878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unmet substance abuse treatment need, health services utilization, and cost: a population-based emergency department study.
    Rockett IR; Putnam SL; Jia H; Chang CF; Smith GS
    Ann Emerg Med; 2005 Feb; 45(2):118-27. PubMed ID: 15671966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment for substance use disorders in a privately insured population under managed care: costs and services use.
    Greenfield SF; Azzone V; Huskamp H; Cuffel B; Croghan T; Goldman W; Frank RG
    J Subst Abuse Treat; 2004 Dec; 27(4):265-75. PubMed ID: 15610828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing substance dependence in elderly people: the side effects program.
    Brymer C; Rusnell I
    Can J Clin Pharmacol; 2000; 7(3):161-6. PubMed ID: 11044762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study.
    Humphreys K; Moos R
    Alcohol Clin Exp Res; 2001 May; 25(5):711-6. PubMed ID: 11371720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.